ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 58 filers reported holding ANNOVIS BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,671,000 | – | 19,530 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 119,538 | $575,000 | 0.47% |
| Sterling Investment Advisors, Ltd. | 51,038 | $245,000 | 0.09% |
| Independence Advisors, LLC | 45,598 | $219,000 | 0.05% |
| Cannell & Co. | 10,000 | $48,000 | 0.00% |
| Paloma Partners Management Co | 17,164 | $83,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 14,286 | $69,000 | 0.00% |
| BROWN ADVISORY INC | 14,942 | $72,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 13,300 | $64,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,236 | $6,000 | 0.00% |